🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
14/12/2022 0,7300 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/10/1971 1,47 1,48 1,46 1,46 -0,90% 1,69% 596.102
25/10/1971 1,47 1,48 1,47 1,47 +0,00% 0,67% 407.462
22/10/1971 1,47 1,49 1,47 1,47 -0,22% 1,57% 1.245.024
21/10/1971 1,47 1,47 1,46 1,47 +0,22% 1,01% 1.033.747
20/10/1971 1,51 1,52 1,47 1,47 -2,63% 3,18% 2.195.770
19/10/1971 1,49 1,51 1,49 1,51 +1,33% 1,66% 913.018
18/10/1971 1,53 1,53 1,49 1,49 -2,60% 2,60% 1.199.750
15/10/1971 1,55 1,55 1,52 1,53 -0,96% 1,50% 731.923
14/10/1971 1,55 1,56 1,54 1,55 -0,11% 0,75% 671.558
13/10/1971 1,53 1,55 1,53 1,55 +1,30% 0,97% 837.562
12/10/1971 1,53 1,54 1,52 1,53 +0,00% 1,30% 731.923
11/10/1971 1,53 1,53 1,52 1,53 -0,10% 0,22% 203.731
08/10/1971 1,52 1,53 1,52 1,53 +0,54% 0,76% 905.472
07/10/1971 1,52 1,53 1,52 1,52 +0,44% 1,09% 2.618.323
06/10/1971 1,50 1,51 1,50 1,51 +1,67% 1,22% 1.350.662
05/10/1971 1,48 1,49 1,47 1,49 +0,34% 1,79% 611.194
04/10/1971 1,48 1,49 1,47 1,48 +0,00% 1,23% 1.712.851
01/10/1971 1,49 1,49 1,47 1,48 -0,22% 1,11% 581.011
30/09/1971 1,47 1,49 1,47 1,49 +1,12% 1,35% 724.378
29/09/1971 1,47 1,48 1,47 1,47 -0,22% 0,68% 377.280
28/09/1971 1,46 1,48 1,46 1,47 +0,79% 1,36% 573.466
27/09/1971 1,48 1,48 1,45 1,46 -1,34% 1,79% 807.379
24/09/1971 1,48 1,49 1,47 1,48 +0,11% 1,01% 686.650
23/09/1971 1,48 1,48 1,47 1,48 +0,22% 0,79% 830.016
22/09/1971 1,49 1,49 1,47 1,48 -1,00% 1,44% 1.146.931
21/09/1971 1,49 1,49 1,48 1,49 +0,11% 1,00% 528.192
20/09/1971 1,49 1,49 1,48 1,49 +0,00% 1,11% 1.290.298
17/09/1971 1,48 1,51 1,48 1,49 +1,35% 2,02% 2.942.784
16/09/1971 1,46 1,48 1,46 1,47 +1,14% 1,13% 1.501.574
15/09/1971 1,44 1,45 1,43 1,45 +1,15% 1,38% 1.056.384